

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.32287292 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.00488963 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.99064064 |
| 4 | vocalization behavior (GO:0071625) | 4.70939308 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.68827476 |
| 6 | glycine transport (GO:0015816) | 4.64432820 |
| 7 | adhesion of symbiont to host cell (GO:0044650) | 4.57827755 |
| 8 | virion attachment to host cell (GO:0019062) | 4.57827755 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.55216807 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.55141990 |
| 11 | positive regulation of male gonad development (GO:2000020) | 4.55102191 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.46115031 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.42680764 |
| 14 | protein localization to synapse (GO:0035418) | 4.33161344 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.26349206 |
| 16 | regulation of chronic inflammatory response (GO:0002676) | 4.22353876 |
| 17 | diaphragm development (GO:0060539) | 4.14234622 |
| 18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.12957573 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.11913101 |
| 20 | glutamate secretion (GO:0014047) | 4.09681105 |
| 21 | cell adhesion mediated by integrin (GO:0033627) | 3.99601537 |
| 22 | metanephric mesenchyme development (GO:0072075) | 3.97707104 |
| 23 | adhesion of symbiont to host (GO:0044406) | 3.95697194 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 3.90794665 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.88434265 |
| 26 | skeletal muscle organ development (GO:0060538) | 3.84446678 |
| 27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.83233582 |
| 28 | kidney mesenchyme development (GO:0072074) | 3.82691323 |
| 29 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.79103573 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.78317000 |
| 31 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.75738095 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74380167 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.73574172 |
| 34 | regulation of podosome assembly (GO:0071801) | 3.73038183 |
| 35 | positive regulation of heat generation (GO:0031652) | 3.70677518 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.69877188 |
| 37 | substrate-dependent cell migration (GO:0006929) | 3.65867362 |
| 38 | innervation (GO:0060384) | 3.65324341 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 3.64470846 |
| 40 | positive regulation of vesicle fusion (GO:0031340) | 3.63903532 |
| 41 | regulation of fever generation (GO:0031620) | 3.63372330 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 3.58191661 |
| 43 | regulation of vitamin metabolic process (GO:0030656) | 3.58147232 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.58028645 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.55616916 |
| 46 | regulation of male gonad development (GO:2000018) | 3.53698968 |
| 47 | regulation of vesicle fusion (GO:0031338) | 3.52841269 |
| 48 | exploration behavior (GO:0035640) | 3.52115833 |
| 49 | proline transport (GO:0015824) | 3.41494809 |
| 50 | regulation of chemokine biosynthetic process (GO:0045073) | 3.41264716 |
| 51 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.38398037 |
| 52 | neuron-neuron synaptic transmission (GO:0007270) | 3.37654834 |
| 53 | long-term synaptic potentiation (GO:0060291) | 3.36288174 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.34961215 |
| 55 | skin morphogenesis (GO:0043589) | 3.33220973 |
| 56 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.30921779 |
| 57 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.30748810 |
| 58 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.30138258 |
| 59 | glomerular basement membrane development (GO:0032836) | 3.28716921 |
| 60 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.27156694 |
| 61 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.24697933 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.24457389 |
| 63 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.23552956 |
| 64 | regulation of postsynaptic membrane potential (GO:0060078) | 3.23125221 |
| 65 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.22628720 |
| 66 | regulation of synapse structural plasticity (GO:0051823) | 3.21411610 |
| 67 | negative regulation of amino acid transport (GO:0051956) | 3.19757549 |
| 68 | neuronal action potential propagation (GO:0019227) | 3.19272295 |
| 69 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.18742357 |
| 70 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.16712939 |
| 71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.15892064 |
| 72 | negative regulation of metanephros development (GO:0072217) | 3.15543712 |
| 73 | regulation of gonadotropin secretion (GO:0032276) | 3.15537804 |
| 74 | type B pancreatic cell proliferation (GO:0044342) | 3.13464714 |
| 75 | regulation of immunoglobulin secretion (GO:0051023) | 3.13035728 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.12779903 |
| 77 | activation of protein kinase A activity (GO:0034199) | 3.11824173 |
| 78 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.11347761 |
| 79 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.10042683 |
| 80 | axon extension involved in axon guidance (GO:0048846) | 3.10042683 |
| 81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.07321924 |
| 82 | layer formation in cerebral cortex (GO:0021819) | 3.06651988 |
| 83 | mechanosensory behavior (GO:0007638) | 3.06563502 |
| 84 | protein heterotrimerization (GO:0070208) | 3.06502439 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 3.04557584 |
| 86 | synaptic vesicle endocytosis (GO:0048488) | 3.03429153 |
| 87 | long-term memory (GO:0007616) | 3.02609451 |
| 88 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.02006974 |
| 89 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.99908133 |
| 90 | cerebellar granule cell differentiation (GO:0021707) | 2.99845771 |
| 91 | membrane depolarization during action potential (GO:0086010) | 2.99502664 |
| 92 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.98958239 |
| 93 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.98243884 |
| 94 | neurotransmitter transport (GO:0006836) | 2.98168678 |
| 95 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.97616411 |
| 96 | regulation of heat generation (GO:0031650) | 2.97270830 |
| 97 | glial cell migration (GO:0008347) | 2.95382344 |
| 98 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.95079191 |
| 99 | sodium ion export (GO:0071436) | 2.94260050 |
| 100 | dendritic spine morphogenesis (GO:0060997) | 2.93843966 |
| 101 | muscle cell cellular homeostasis (GO:0046716) | 2.93150417 |
| 102 | detection of calcium ion (GO:0005513) | 2.92935073 |
| 103 | regulation of synaptic plasticity (GO:0048167) | 2.91648582 |
| 104 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.91306768 |
| 105 | positive regulation of membrane potential (GO:0045838) | 2.91256048 |
| 106 | positive regulation of synapse assembly (GO:0051965) | 2.89443820 |
| 107 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.89378875 |
| 108 | extracellular matrix assembly (GO:0085029) | 2.86494059 |
| 109 | membrane hyperpolarization (GO:0060081) | 2.84658371 |
| 110 | cell communication by electrical coupling (GO:0010644) | 2.84332573 |
| 111 | postsynaptic membrane organization (GO:0001941) | 2.83427790 |
| 112 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.83340055 |
| 113 | extracellular fibril organization (GO:0043206) | 2.83012185 |
| 114 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.82994585 |
| 115 | response to histamine (GO:0034776) | 2.82533645 |
| 116 | collagen fibril organization (GO:0030199) | 2.81085472 |
| 117 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.80745188 |
| 118 | membrane depolarization (GO:0051899) | 2.80341737 |
| 119 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.80266628 |
| 120 | auditory behavior (GO:0031223) | 2.79163352 |
| 121 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.78832426 |
| 122 | endocardial cushion development (GO:0003197) | 2.78798378 |
| 123 | gamma-aminobutyric acid transport (GO:0015812) | 2.77720714 |
| 124 | regulation of neurotransmitter transport (GO:0051588) | 2.75786611 |
| 125 | regulation of synapse maturation (GO:0090128) | 2.74286145 |
| 126 | neuron recognition (GO:0008038) | 2.73807956 |
| 127 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.73762660 |
| 128 | long term synaptic depression (GO:0060292) | 2.73756420 |
| 129 | response to gonadotropin (GO:0034698) | 2.72971542 |
| 130 | mating behavior (GO:0007617) | 2.72867809 |
| 131 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.72829726 |
| 132 | potassium ion homeostasis (GO:0055075) | 2.72631545 |
| 133 | response to auditory stimulus (GO:0010996) | 2.71610675 |
| 134 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.71315217 |
| 135 | positive regulation of synaptic transmission (GO:0050806) | 2.71314574 |
| 136 | chondroitin sulfate catabolic process (GO:0030207) | 2.70405300 |
| 137 | positive regulation of astrocyte differentiation (GO:0048711) | 2.69985779 |
| 138 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.68641802 |
| 139 | presynaptic membrane assembly (GO:0097105) | 2.67152759 |
| 140 | fibril organization (GO:0097435) | 2.66203690 |
| 141 | suckling behavior (GO:0001967) | 2.65733260 |
| 142 | ganglion development (GO:0061548) | 2.65628247 |
| 143 | behavioral fear response (GO:0001662) | 2.65464478 |
| 144 | behavioral defense response (GO:0002209) | 2.65464478 |
| 145 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.65406923 |
| 146 | fibroblast migration (GO:0010761) | 2.64298761 |
| 147 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.63999417 |
| 148 | chemosensory behavior (GO:0007635) | 2.63957078 |
| 149 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.63938414 |
| 150 | axonal fasciculation (GO:0007413) | 2.63547886 |
| 151 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.62816655 |
| 152 | response to pheromone (GO:0019236) | 2.62631801 |
| 153 | signal release (GO:0023061) | 2.62173311 |
| 154 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.62010496 |
| 155 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.62004204 |
| 156 | neuromuscular process controlling posture (GO:0050884) | 2.61875322 |
| 157 | regulation of beta-amyloid formation (GO:1902003) | 2.61850080 |
| 158 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.61444419 |
| 159 | synaptic transmission (GO:0007268) | 2.61040902 |
| 160 | synapse assembly (GO:0007416) | 2.60712249 |
| 161 | regulation of neurotransmitter levels (GO:0001505) | 2.60328624 |
| 162 | cellular response to gonadotropin stimulus (GO:0071371) | 2.59552055 |
| 163 | decidualization (GO:0046697) | 2.58386792 |
| 164 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.55506408 |
| 165 | regulation of mononuclear cell migration (GO:0071675) | 2.55006329 |
| 166 | endocytic recycling (GO:0032456) | 2.49891138 |
| 167 | dermatan sulfate biosynthetic process (GO:0030208) | 2.48125519 |
| 168 | eosinophil chemotaxis (GO:0048245) | 2.47155334 |
| 169 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.46480887 |
| 170 | axon extension (GO:0048675) | 2.45776603 |
| 171 | endodermal cell differentiation (GO:0035987) | 2.44978461 |
| 172 | negative regulation of monooxygenase activity (GO:0032769) | 2.44813786 |
| 173 | dermatan sulfate metabolic process (GO:0030205) | 2.43670264 |
| 174 | positive regulation of metanephros development (GO:0072216) | 2.43518310 |
| 175 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.43159984 |
| 176 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.41444988 |
| 177 | endoderm formation (GO:0001706) | 2.41134240 |
| 178 | negative regulation of axon guidance (GO:1902668) | 2.39754653 |
| 179 | regulation of axon guidance (GO:1902667) | 2.39446221 |
| 180 | regulation of metanephros development (GO:0072215) | 2.38735505 |
| 181 | keratan sulfate catabolic process (GO:0042340) | 2.38126870 |
| 182 | cellular response to interferon-alpha (GO:0035457) | 2.36617000 |
| 183 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.35878889 |
| 184 | chondrocyte proliferation (GO:0035988) | 2.35628148 |
| 185 | cellular response to nicotine (GO:0071316) | 2.35540449 |
| 186 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.35002640 |
| 187 | negative chemotaxis (GO:0050919) | 2.33729134 |
| 188 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.32565616 |
| 189 | response to gravity (GO:0009629) | 2.31010944 |
| 190 | regulation of glomerulus development (GO:0090192) | 2.30996820 |
| 191 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.30648887 |
| 192 | regulation of glutamate secretion (GO:0014048) | 2.27319150 |
| 193 | protein localization to endosome (GO:0036010) | 2.26470006 |
| 194 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.25924485 |
| 195 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.25544541 |
| 196 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.24522559 |
| 197 | negative regulation of macrophage differentiation (GO:0045650) | 2.24500221 |
| 198 | stress fiber assembly (GO:0043149) | 2.23920907 |
| 199 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.22761387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.59705053 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53452559 |
| 3 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.42110583 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03331763 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99757292 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.69032414 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.62367749 |
| 8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.55572219 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.52156869 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51050498 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50108289 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47692142 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47692142 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45270271 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.42915348 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38928559 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36099240 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36010973 |
| 19 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.31853899 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.31707918 |
| 21 | CJUN_26792858_Chip-Seq_BT549_Human | 2.29387408 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.28243775 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23266916 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19198675 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.18395997 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15537527 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12603224 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07615678 |
| 29 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.05759139 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98713703 |
| 31 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.96505257 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.94955909 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.91644137 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91331296 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91123621 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83505897 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.81340046 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.81340046 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80741946 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80341652 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77278440 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76998972 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.73541641 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73350826 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67874893 |
| 46 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67677777 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.65771398 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64866331 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63345984 |
| 50 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59329668 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.58989222 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58362675 |
| 53 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.55480151 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.54890646 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49472786 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49198046 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48264623 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48039750 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46417824 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45768693 |
| 61 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.45719248 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43519683 |
| 63 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43178277 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42597654 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.41006408 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38975884 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38629035 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37666173 |
| 69 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.34293498 |
| 70 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.33792185 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33577478 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33219980 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32653404 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32566966 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31345790 |
| 76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30718166 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27398694 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27019238 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.26800760 |
| 80 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.26564400 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26538657 |
| 82 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26304201 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26302821 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25678965 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24853541 |
| 86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.24157307 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22721211 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22543616 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20449681 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19891033 |
| 91 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.19797641 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19117839 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.18883852 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18842120 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18610291 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17354559 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15985084 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14202398 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13879379 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13717359 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13417027 |
| 102 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12848293 |
| 103 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12599109 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11646446 |
| 105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11361625 |
| 106 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10779960 |
| 107 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10694892 |
| 108 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10694892 |
| 109 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.10411836 |
| 110 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10269981 |
| 111 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09462749 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07991912 |
| 113 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07165782 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06712792 |
| 115 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06518639 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05392732 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05191674 |
| 118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04857975 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03989346 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.03928427 |
| 121 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.01819808 |
| 122 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99709117 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99548847 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99358334 |
| 125 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97680277 |
| 126 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97388600 |
| 127 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96615299 |
| 128 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96502207 |
| 129 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95619423 |
| 130 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95192223 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94467942 |
| 132 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94390462 |
| 133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93825761 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93812377 |
| 135 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92955934 |
| 136 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91055862 |
| 137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90740297 |
| 138 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90475736 |
| 139 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89237849 |
| 140 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89159601 |
| 141 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88679641 |
| 142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88044360 |
| 143 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87963184 |
| 144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87755954 |
| 145 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87567709 |
| 146 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86850840 |
| 147 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86637247 |
| 148 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86548215 |
| 149 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86201069 |
| 150 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85445045 |
| 151 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85070840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.59407205 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.05619179 |
| 3 | MP0005257_abnormal_intraocular_pressure | 4.11708918 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.44457583 |
| 5 | MP0004270_analgesia | 3.12808020 |
| 6 | MP0003880_abnormal_central_pattern | 3.09034330 |
| 7 | MP0003279_aneurysm | 3.05192459 |
| 8 | MP0003303_peritoneal_inflammation | 2.93178852 |
| 9 | MP0001542_abnormal_bone_strength | 2.92026753 |
| 10 | MP0009745_abnormal_behavioral_response | 2.87532378 |
| 11 | MP0009046_muscle_twitch | 2.85540175 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.82039664 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.78947594 |
| 14 | MP0002064_seizures | 2.76510090 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.70397398 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.68446131 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.65860239 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.63677991 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.61612843 |
| 20 | MP0002572_abnormal_emotion/affect_behav | 2.50677087 |
| 21 | MP0006054_spinal_hemorrhage | 2.49712722 |
| 22 | MP0001958_emphysema | 2.48979360 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.44399443 |
| 24 | MP0004272_abnormal_basement_membrane | 2.36586773 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.36281247 |
| 26 | MP0002272_abnormal_nervous_system | 2.31902700 |
| 27 | MP0005645_abnormal_hypothalamus_physiol | 2.29553810 |
| 28 | MP0005551_abnormal_eye_electrophysiolog | 2.21285204 |
| 29 | MP0002735_abnormal_chemical_nociception | 2.20157226 |
| 30 | MP0003091_abnormal_cell_migration | 2.11585087 |
| 31 | MP0002909_abnormal_adrenal_gland | 2.09850994 |
| 32 | MP0002736_abnormal_nociception_after | 2.09027839 |
| 33 | MP0000749_muscle_degeneration | 2.05823020 |
| 34 | MP0001501_abnormal_sleep_pattern | 2.01398026 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.99914946 |
| 36 | MP0003787_abnormal_imprinting | 1.94096358 |
| 37 | MP0003122_maternal_imprinting | 1.91895467 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.91112431 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.88646101 |
| 40 | MP0005503_abnormal_tendon_morphology | 1.88355543 |
| 41 | MP0002184_abnormal_innervation | 1.87378463 |
| 42 | MP0004858_abnormal_nervous_system | 1.86156735 |
| 43 | MP0001486_abnormal_startle_reflex | 1.84859902 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.84454162 |
| 45 | MP0002067_abnormal_sensory_capabilities | 1.83789024 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.83335940 |
| 47 | MP0002822_catalepsy | 1.82256259 |
| 48 | MP0005275_abnormal_skin_tensile | 1.79998269 |
| 49 | MP0005595_abnormal_vascular_smooth | 1.79854290 |
| 50 | MP0006082_CNS_inflammation | 1.78406493 |
| 51 | MP0005623_abnormal_meninges_morphology | 1.77726408 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.77228856 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.77197952 |
| 54 | MP0009840_abnormal_foam_cell | 1.77056295 |
| 55 | MP0005423_abnormal_somatic_nervous | 1.75369343 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.74408333 |
| 57 | MP0005508_abnormal_skeleton_morphology | 1.71223166 |
| 58 | MP0003879_abnormal_hair_cell | 1.70827341 |
| 59 | MP0008569_lethality_at_weaning | 1.69182465 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.66996082 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.65647361 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.63894916 |
| 63 | MP0001970_abnormal_pain_threshold | 1.62810293 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.59641587 |
| 65 | MP0001984_abnormal_olfaction | 1.59012481 |
| 66 | MP0003075_altered_response_to | 1.58687435 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.58049716 |
| 68 | MP0000343_altered_response_to | 1.57037967 |
| 69 | MP0002896_abnormal_bone_mineralization | 1.47976127 |
| 70 | MP0005253_abnormal_eye_physiology | 1.47524406 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.47250420 |
| 72 | MP0000778_abnormal_nervous_system | 1.46213188 |
| 73 | MP0003329_amyloid_beta_deposits | 1.45707169 |
| 74 | MP0010368_abnormal_lymphatic_system | 1.44907717 |
| 75 | MP0005023_abnormal_wound_healing | 1.42887196 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.42206838 |
| 77 | MP0004924_abnormal_behavior | 1.42206838 |
| 78 | MP0004811_abnormal_neuron_physiology | 1.41804899 |
| 79 | MP0004885_abnormal_endolymph | 1.39987009 |
| 80 | MP0000003_abnormal_adipose_tissue | 1.38690826 |
| 81 | MP0002090_abnormal_vision | 1.37667120 |
| 82 | MP0006276_abnormal_autonomic_nervous | 1.37211908 |
| 83 | MP0001243_abnormal_dermal_layer | 1.37169162 |
| 84 | MP0004233_abnormal_muscle_weight | 1.33177458 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.31830638 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 1.29880316 |
| 87 | MP0004215_abnormal_myocardial_fiber | 1.25529473 |
| 88 | MP0003123_paternal_imprinting | 1.23437565 |
| 89 | MP0003195_calcinosis | 1.21840380 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 1.20065158 |
| 91 | MP0003633_abnormal_nervous_system | 1.18257280 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 1.17458025 |
| 93 | MP0000955_abnormal_spinal_cord | 1.17137711 |
| 94 | MP0010030_abnormal_orbit_morphology | 1.16600716 |
| 95 | MP0000751_myopathy | 1.16481695 |
| 96 | MP0004043_abnormal_pH_regulation | 1.13093025 |
| 97 | MP0005390_skeleton_phenotype | 1.12629932 |
| 98 | MP0002876_abnormal_thyroid_physiology | 1.12244097 |
| 99 | MP0003448_altered_tumor_morphology | 1.11799103 |
| 100 | MP0005197_abnormal_uvea_morphology | 1.11776631 |
| 101 | MP0002066_abnormal_motor_capabilities/c | 1.11672415 |
| 102 | MP0005165_increased_susceptibility_to | 1.10994374 |
| 103 | MP0008961_abnormal_basal_metabolism | 1.08658903 |
| 104 | MP0001529_abnormal_vocalization | 1.07758117 |
| 105 | MP0003300_gastrointestinal_ulcer | 1.04178139 |
| 106 | MP0002229_neurodegeneration | 1.01242216 |
| 107 | MP0005164_abnormal_response_to | 1.01031216 |
| 108 | MP0000538_abnormal_urinary_bladder | 0.98320905 |
| 109 | MP0002653_abnormal_ependyma_morphology | 0.96529421 |
| 110 | MP0003631_nervous_system_phenotype | 0.94790761 |
| 111 | MP0000604_amyloidosis | 0.94726461 |
| 112 | MP0000920_abnormal_myelination | 0.94669684 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.91695538 |
| 114 | MP0004085_abnormal_heartbeat | 0.91581450 |
| 115 | MP0000759_abnormal_skeletal_muscle | 0.91113523 |
| 116 | MP0000733_abnormal_muscle_development | 0.90779624 |
| 117 | MP0001533_abnormal_skeleton_physiology | 0.90314347 |
| 118 | MP0002751_abnormal_autonomic_nervous | 0.88594836 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.87960517 |
| 120 | MP0003942_abnormal_urinary_system | 0.87689887 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.87450149 |
| 122 | MP0002152_abnormal_brain_morphology | 0.86795344 |
| 123 | MP0001727_abnormal_embryo_implantation | 0.85376797 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.85186256 |
| 125 | MP0008004_abnormal_stomach_pH | 0.84937957 |
| 126 | MP0003045_fibrosis | 0.84349707 |
| 127 | MP0001188_hyperpigmentation | 0.83955570 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.83580793 |
| 129 | MP0001853_heart_inflammation | 0.83239582 |
| 130 | MP0004142_abnormal_muscle_tone | 0.82943041 |
| 131 | MP0003634_abnormal_glial_cell | 0.82644288 |
| 132 | MP0005084_abnormal_gallbladder_morpholo | 0.82052061 |
| 133 | MP0001299_abnormal_eye_distance/ | 0.81747820 |
| 134 | MP0002148_abnormal_hypersensitivity_rea | 0.81485928 |
| 135 | MP0004742_abnormal_vestibular_system | 0.80129609 |
| 136 | MP0004510_myositis | 0.79971432 |
| 137 | MP0003283_abnormal_digestive_organ | 0.79439185 |
| 138 | MP0000163_abnormal_cartilage_morphology | 0.79031365 |
| 139 | MP0001944_abnormal_pancreas_morphology | 0.78993922 |
| 140 | MP0000639_abnormal_adrenal_gland | 0.78718801 |
| 141 | MP0009250_abnormal_appendicular_skeleto | 0.78390501 |
| 142 | MP0002752_abnormal_somatic_nervous | 0.78253503 |
| 143 | MP0002282_abnormal_trachea_morphology | 0.77150625 |
| 144 | MP0003121_genomic_imprinting | 0.77086079 |
| 145 | MP0002168_other_aberrant_phenotype | 0.76249898 |
| 146 | MP0003453_abnormal_keratinocyte_physiol | 0.75644905 |
| 147 | MP0002139_abnormal_hepatobiliary_system | 0.75357312 |
| 148 | MP0009764_decreased_sensitivity_to | 0.75347150 |
| 149 | MP0002115_abnormal_skeleton_extremities | 0.75322951 |
| 150 | MP0003137_abnormal_impulse_conducting | 0.74063153 |
| 151 | MP0005535_abnormal_body_temperature | 0.74050321 |
| 152 | MP0002060_abnormal_skin_morphology | 0.73167367 |
| 153 | MP0003828_pulmonary_edema | 0.73100534 |
| 154 | MP0001348_abnormal_lacrimal_gland | 0.73005703 |
| 155 | MP0005171_absent_coat_pigmentation | 0.72507965 |
| 156 | MP0005195_abnormal_posterior_eye | 0.71696881 |
| 157 | MP0005187_abnormal_penis_morphology | 0.71579767 |
| 158 | MP0001963_abnormal_hearing_physiology | 0.71307104 |
| 159 | MP0002254_reproductive_system_inflammat | 0.70438697 |
| 160 | MP0003632_abnormal_nervous_system | 0.69907117 |
| 161 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69655201 |
| 162 | MP0002972_abnormal_cardiac_muscle | 0.69129479 |
| 163 | MP0005379_endocrine/exocrine_gland_phen | 0.68968791 |
| 164 | MP0003172_abnormal_lysosome_physiology | 0.68599700 |
| 165 | MP0002998_abnormal_bone_remodeling | 0.68262494 |
| 166 | MP0003186_abnormal_redox_activity | 0.66942772 |
| 167 | MP0000534_abnormal_ureter_morphology | 0.66928076 |
| 168 | MP0004036_abnormal_muscle_relaxation | 0.66068075 |
| 169 | MP0005166_decreased_susceptibility_to | 0.63071854 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.63043576 |
| 171 | MP0003385_abnormal_body_wall | 0.62732526 |
| 172 | MP0005367_renal/urinary_system_phenotyp | 0.60780712 |
| 173 | MP0000516_abnormal_urinary_system | 0.60780712 |
| 174 | MP0002693_abnormal_pancreas_physiology | 0.59902933 |
| 175 | MP0001765_abnormal_ion_homeostasis | 0.59014898 |
| 176 | MP0004484_altered_response_of | 0.58393640 |
| 177 | MP0005620_abnormal_muscle_contractility | 0.57166437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.80345877 |
| 2 | Focal motor seizures (HP:0011153) | 5.40027552 |
| 3 | Protrusio acetabuli (HP:0003179) | 5.01456302 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.66999022 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.43762163 |
| 6 | Focal seizures (HP:0007359) | 4.21204189 |
| 7 | Myokymia (HP:0002411) | 4.16695395 |
| 8 | Atonic seizures (HP:0010819) | 4.06850312 |
| 9 | Febrile seizures (HP:0002373) | 4.02261119 |
| 10 | Visual hallucinations (HP:0002367) | 3.94492536 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.89146099 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.89146099 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.89146099 |
| 14 | Mesangial abnormality (HP:0001966) | 3.76685826 |
| 15 | Action tremor (HP:0002345) | 3.71566834 |
| 16 | Absence seizures (HP:0002121) | 3.66556395 |
| 17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.63196941 |
| 18 | Hemiparesis (HP:0001269) | 3.42640629 |
| 19 | Vertebral compression fractures (HP:0002953) | 3.30317569 |
| 20 | Nuclear cataract (HP:0100018) | 3.29181273 |
| 21 | Dialeptic seizures (HP:0011146) | 3.25440034 |
| 22 | Ankle contracture (HP:0006466) | 3.23868963 |
| 23 | Retinal atrophy (HP:0001105) | 3.15055515 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.14250891 |
| 25 | Congenital stationary night blindness (HP:0007642) | 3.13221143 |
| 26 | Central scotoma (HP:0000603) | 3.12978778 |
| 27 | Hyperventilation (HP:0002883) | 3.11812084 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.10435859 |
| 29 | Genetic anticipation (HP:0003743) | 3.06159851 |
| 30 | Agitation (HP:0000713) | 3.03639338 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 2.98456482 |
| 32 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.98443892 |
| 33 | Aortic dissection (HP:0002647) | 2.96139073 |
| 34 | Pheochromocytoma (HP:0002666) | 2.94974918 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89651472 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89651472 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89651472 |
| 38 | Bladder diverticulum (HP:0000015) | 2.88042112 |
| 39 | Spinal rigidity (HP:0003306) | 2.87934898 |
| 40 | Neonatal short-limb short stature (HP:0008921) | 2.86162711 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.82570902 |
| 42 | Depression (HP:0000716) | 2.81843933 |
| 43 | Abnormality of macular pigmentation (HP:0008002) | 2.80835398 |
| 44 | Cervical subluxation (HP:0003308) | 2.79825090 |
| 45 | Axonal loss (HP:0003447) | 2.79536426 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.77674786 |
| 47 | Broad-based gait (HP:0002136) | 2.76784759 |
| 48 | Abnormality of dentin (HP:0010299) | 2.75963926 |
| 49 | Follicular hyperkeratosis (HP:0007502) | 2.74341971 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.71347960 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71347960 |
| 52 | Blue irides (HP:0000635) | 2.70203984 |
| 53 | Truncal ataxia (HP:0002078) | 2.70138256 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.66147672 |
| 55 | Aortic aneurysm (HP:0004942) | 2.64581469 |
| 56 | Impaired smooth pursuit (HP:0007772) | 2.64422750 |
| 57 | Distal upper limb amyotrophy (HP:0007149) | 2.61581250 |
| 58 | Upper limb amyotrophy (HP:0009129) | 2.61581250 |
| 59 | Atrophic scars (HP:0001075) | 2.59361714 |
| 60 | Mitral stenosis (HP:0001718) | 2.57149285 |
| 61 | Neuroendocrine neoplasm (HP:0100634) | 2.55588320 |
| 62 | Anxiety (HP:0000739) | 2.54816018 |
| 63 | Hypoventilation (HP:0002791) | 2.54655191 |
| 64 | Shallow orbits (HP:0000586) | 2.54564424 |
| 65 | Limb-girdle muscle weakness (HP:0003325) | 2.54170541 |
| 66 | Soft skin (HP:0000977) | 2.51108394 |
| 67 | Genu recurvatum (HP:0002816) | 2.49892048 |
| 68 | Type 1 muscle fiber predominance (HP:0003803) | 2.48269566 |
| 69 | Hand muscle atrophy (HP:0009130) | 2.47446344 |
| 70 | Hypsarrhythmia (HP:0002521) | 2.46020294 |
| 71 | Slender build (HP:0001533) | 2.45137476 |
| 72 | Menstrual irregularities (HP:0000858) | 2.43776017 |
| 73 | Scanning speech (HP:0002168) | 2.43017346 |
| 74 | Aortic regurgitation (HP:0001659) | 2.42414000 |
| 75 | Dysmetric saccades (HP:0000641) | 2.42089740 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.41961692 |
| 77 | Vascular tortuosity (HP:0004948) | 2.40522138 |
| 78 | Supranuclear gaze palsy (HP:0000605) | 2.40323080 |
| 79 | Poor eye contact (HP:0000817) | 2.36409170 |
| 80 | Excessive salivation (HP:0003781) | 2.36302506 |
| 81 | Drooling (HP:0002307) | 2.36302506 |
| 82 | Tibial bowing (HP:0002982) | 2.31540202 |
| 83 | Scotoma (HP:0000575) | 2.31493902 |
| 84 | Shoulder girdle muscle weakness (HP:0003547) | 2.31015393 |
| 85 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.30437384 |
| 86 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.30187208 |
| 87 | Wormian bones (HP:0002645) | 2.28905177 |
| 88 | Mitral regurgitation (HP:0001653) | 2.28349514 |
| 89 | Bowel diverticulosis (HP:0005222) | 2.27675303 |
| 90 | Hypercortisolism (HP:0001578) | 2.27501316 |
| 91 | Joint stiffness (HP:0001387) | 2.27285604 |
| 92 | Dysmetria (HP:0001310) | 2.24151789 |
| 93 | Spondylolisthesis (HP:0003302) | 2.23778570 |
| 94 | Abnormal social behavior (HP:0012433) | 2.18829538 |
| 95 | Impaired social interactions (HP:0000735) | 2.18829538 |
| 96 | Macroorchidism (HP:0000053) | 2.16502234 |
| 97 | J-shaped sella turcica (HP:0002680) | 2.16358803 |
| 98 | Round ear (HP:0100830) | 2.15429248 |
| 99 | Delayed gross motor development (HP:0002194) | 2.14732416 |
| 100 | Papilledema (HP:0001085) | 2.10598657 |
| 101 | Cerebral aneurysm (HP:0004944) | 2.09224190 |
| 102 | Prolonged QT interval (HP:0001657) | 2.07806008 |
| 103 | Thin bony cortex (HP:0002753) | 2.06550097 |
| 104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05752941 |
| 105 | Abnormal eating behavior (HP:0100738) | 2.05083540 |
| 106 | Biconcave vertebral bodies (HP:0004586) | 2.04800130 |
| 107 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.03128153 |
| 108 | Postural tremor (HP:0002174) | 2.02810581 |
| 109 | Wrist flexion contracture (HP:0001239) | 2.02627185 |
| 110 | Short nail (HP:0001799) | 2.01617234 |
| 111 | Fragile skin (HP:0001030) | 2.00751486 |
| 112 | Amblyopia (HP:0000646) | 1.99697228 |
| 113 | Hypoplastic left heart (HP:0004383) | 1.99428031 |
| 114 | Hemiplegia (HP:0002301) | 1.98486505 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.96038726 |
| 116 | Gait imbalance (HP:0002141) | 1.95779959 |
| 117 | Choroideremia (HP:0001139) | 1.95602648 |
| 118 | Protruding tongue (HP:0010808) | 1.94330130 |
| 119 | Broad metatarsal (HP:0001783) | 1.94169322 |
| 120 | Arterial tortuosity (HP:0005116) | 1.93929195 |
| 121 | Ventricular fibrillation (HP:0001663) | 1.90953645 |
| 122 | Hypoplastic heart (HP:0001961) | 1.90262350 |
| 123 | Ankyloglossia (HP:0010296) | 1.89933619 |
| 124 | Postural instability (HP:0002172) | 1.87610094 |
| 125 | Mutism (HP:0002300) | 1.86147961 |
| 126 | Congenital primary aphakia (HP:0007707) | 1.85891784 |
| 127 | Torticollis (HP:0000473) | 1.84689509 |
| 128 | Abnormality of the fovea (HP:0000493) | 1.83685155 |
| 129 | Ankle clonus (HP:0011448) | 1.83331390 |
| 130 | Generalized amyotrophy (HP:0003700) | 1.82594863 |
| 131 | Aortic valve stenosis (HP:0001650) | 1.82115987 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.82054451 |
| 133 | Blue sclerae (HP:0000592) | 1.81979050 |
| 134 | Hyperacusis (HP:0010780) | 1.81718532 |
| 135 | Apathy (HP:0000741) | 1.81468858 |
| 136 | Cerebral inclusion bodies (HP:0100314) | 1.81370664 |
| 137 | Long toe (HP:0010511) | 1.81147804 |
| 138 | Increased circulating renin level (HP:0000848) | 1.81051061 |
| 139 | Stereotypic behavior (HP:0000733) | 1.80495153 |
| 140 | Pulmonary artery stenosis (HP:0004415) | 1.80282040 |
| 141 | Testicular neoplasm (HP:0010788) | 1.79252207 |
| 142 | Ulnar deviation of the wrist (HP:0003049) | 1.78615283 |
| 143 | Hyperextensible skin (HP:0000974) | 1.77908790 |
| 144 | Absent speech (HP:0001344) | 1.77333208 |
| 145 | Stridor (HP:0010307) | 1.75908865 |
| 146 | Loss of speech (HP:0002371) | 1.75752063 |
| 147 | Gonadal dysgenesis (HP:0000133) | 1.75640298 |
| 148 | Hypoplasia of the odontoid process (HP:0003311) | 1.75506689 |
| 149 | Decreased circulating renin level (HP:0003351) | 1.75484650 |
| 150 | Hypoglycemic seizures (HP:0002173) | 1.75015084 |
| 151 | Neoplasm of the heart (HP:0100544) | 1.74847616 |
| 152 | Hydroureter (HP:0000072) | 1.74638058 |
| 153 | Hammertoe (HP:0001765) | 1.74072708 |
| 154 | Protuberant abdomen (HP:0001538) | 1.74052665 |
| 155 | Diminished motivation (HP:0000745) | 1.73687298 |
| 156 | Flat cornea (HP:0007720) | 1.73672008 |
| 157 | Ovoid vertebral bodies (HP:0003300) | 1.73160229 |
| 158 | Wide anterior fontanel (HP:0000260) | 1.72775137 |
| 159 | Zonular cataract (HP:0010920) | 1.72336081 |
| 160 | Insomnia (HP:0100785) | 1.72243132 |
| 161 | Abnormal EKG (HP:0003115) | 1.72056444 |
| 162 | Abnormality of the lower motor neuron (HP:0002366) | 1.71719211 |
| 163 | Vitreoretinal degeneration (HP:0000655) | 1.71591608 |
| 164 | Intention tremor (HP:0002080) | 1.71358664 |
| 165 | Renal duplication (HP:0000075) | 1.70951538 |
| 166 | Focal dystonia (HP:0004373) | 1.70578635 |
| 167 | Hyperthyroidism (HP:0000836) | 1.70372464 |
| 168 | Growth hormone excess (HP:0000845) | 1.70244913 |
| 169 | Cardiovascular calcification (HP:0011915) | 1.69099189 |
| 170 | Buphthalmos (HP:0000557) | 1.68844323 |
| 171 | Severe visual impairment (HP:0001141) | 1.68797807 |
| 172 | Syncope (HP:0001279) | 1.67919084 |
| 173 | Dilatation of the ascending aorta (HP:0005111) | 1.67625035 |
| 174 | Type II diabetes mellitus (HP:0005978) | 1.66972354 |
| 175 | Beaking of vertebral bodies (HP:0004568) | 1.66070118 |
| 176 | Orthostatic hypotension (HP:0001278) | 1.66013274 |
| 177 | Generalized myoclonic seizures (HP:0002123) | 1.65894273 |
| 178 | Congenital glaucoma (HP:0001087) | 1.65742653 |
| 179 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.65669043 |
| 180 | Abnormality of binocular vision (HP:0011514) | 1.65462693 |
| 181 | Diplopia (HP:0000651) | 1.65462693 |
| 182 | Absent frontal sinuses (HP:0002688) | 1.65143614 |
| 183 | Abnormality of the odontoid process (HP:0003310) | 1.65109697 |
| 184 | Mild short stature (HP:0003502) | 1.64041864 |
| 185 | Retinal dysplasia (HP:0007973) | 1.63141370 |
| 186 | Vacuolated lymphocytes (HP:0001922) | 1.63094747 |
| 187 | Hyperglycemia (HP:0003074) | 1.62630042 |
| 188 | Gait ataxia (HP:0002066) | 1.61999950 |
| 189 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.61775894 |
| 190 | Ectopia lentis (HP:0001083) | 1.61633452 |
| 191 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.61458852 |
| 192 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.60845065 |
| 193 | Nephrogenic diabetes insipidus (HP:0009806) | 1.60511565 |
| 194 | Adrenal overactivity (HP:0002717) | 1.60093406 |
| 195 | Type II lissencephaly (HP:0007260) | 1.59954773 |
| 196 | Abnormality of the periventricular white matter (HP:0002518) | 1.59160832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 4.52314926 |
| 2 | NTRK3 | 4.27429351 |
| 3 | IRAK3 | 4.14785402 |
| 4 | LIMK1 | 3.33712628 |
| 5 | TESK1 | 3.09766151 |
| 6 | MAP3K4 | 3.04938890 |
| 7 | TAOK2 | 2.71010710 |
| 8 | MAP2K7 | 2.67192416 |
| 9 | DAPK2 | 2.65518273 |
| 10 | EPHA4 | 2.60180023 |
| 11 | MOS | 2.55619199 |
| 12 | MAPK15 | 2.44864791 |
| 13 | CASK | 2.29139830 |
| 14 | PDGFRA | 2.21615579 |
| 15 | MAP3K9 | 2.16168446 |
| 16 | LATS2 | 2.07384092 |
| 17 | MYLK | 2.04215363 |
| 18 | PRKD3 | 2.00687653 |
| 19 | MINK1 | 1.98223057 |
| 20 | PIM2 | 1.94861487 |
| 21 | PAK6 | 1.89428158 |
| 22 | NME2 | 1.86744042 |
| 23 | PLK2 | 1.81992745 |
| 24 | EPHB2 | 1.77820354 |
| 25 | RIPK4 | 1.71700603 |
| 26 | MARK1 | 1.70859692 |
| 27 | DAPK1 | 1.70786770 |
| 28 | MAP3K12 | 1.70216645 |
| 29 | WNK4 | 1.68126106 |
| 30 | NEK9 | 1.66674610 |
| 31 | MAP2K4 | 1.62744448 |
| 32 | AKT3 | 1.61382831 |
| 33 | ADRBK2 | 1.59243301 |
| 34 | CCNB1 | 1.58295232 |
| 35 | CAMKK1 | 1.56906954 |
| 36 | CAMKK2 | 1.46839882 |
| 37 | KSR2 | 1.46341223 |
| 38 | NTRK2 | 1.46161381 |
| 39 | ABL2 | 1.44313957 |
| 40 | TTN | 1.42079746 |
| 41 | UHMK1 | 1.38606284 |
| 42 | KSR1 | 1.37613927 |
| 43 | TGFBR2 | 1.31995700 |
| 44 | PKN1 | 1.31265702 |
| 45 | MAP3K2 | 1.29759544 |
| 46 | SGK2 | 1.28602557 |
| 47 | SIK3 | 1.27233057 |
| 48 | WNK1 | 1.26100003 |
| 49 | ERBB4 | 1.25604468 |
| 50 | SGK494 | 1.21819983 |
| 51 | SGK223 | 1.21819983 |
| 52 | CDK5 | 1.21396099 |
| 53 | EPHA3 | 1.20440407 |
| 54 | NTRK1 | 1.19912027 |
| 55 | MAP3K3 | 1.19648531 |
| 56 | GRK5 | 1.19569395 |
| 57 | TAOK1 | 1.17111281 |
| 58 | TRIM28 | 1.17035967 |
| 59 | STK38 | 1.12331816 |
| 60 | INSRR | 1.09371907 |
| 61 | ROCK2 | 1.08086096 |
| 62 | PRKCG | 1.07989526 |
| 63 | PRPF4B | 1.03152817 |
| 64 | CLK1 | 1.03150200 |
| 65 | SGK3 | 1.02634074 |
| 66 | TNIK | 1.00911635 |
| 67 | PRKCH | 0.99534087 |
| 68 | CDC42BPA | 0.98370918 |
| 69 | CAMK2A | 0.98206833 |
| 70 | MAPK13 | 0.97653084 |
| 71 | MAP3K11 | 0.96949048 |
| 72 | PAK4 | 0.95995077 |
| 73 | PAK3 | 0.95792430 |
| 74 | PRKD2 | 0.95481950 |
| 75 | ARAF | 0.95241337 |
| 76 | ROCK1 | 0.95205395 |
| 77 | PHKG2 | 0.94054410 |
| 78 | PHKG1 | 0.94054410 |
| 79 | PIK3CG | 0.93838920 |
| 80 | SIK2 | 0.93374084 |
| 81 | DYRK1A | 0.92583535 |
| 82 | FER | 0.91382639 |
| 83 | RET | 0.90709877 |
| 84 | DMPK | 0.90403209 |
| 85 | SGK1 | 0.89950430 |
| 86 | TBK1 | 0.89929797 |
| 87 | CAMK1 | 0.88944466 |
| 88 | RIPK1 | 0.87052885 |
| 89 | CSNK1G3 | 0.83733129 |
| 90 | CAMK1G | 0.81606233 |
| 91 | CDK19 | 0.79731958 |
| 92 | CAMK2D | 0.77754347 |
| 93 | CAMK2B | 0.77185623 |
| 94 | PTK2B | 0.76633641 |
| 95 | MAP3K1 | 0.75174096 |
| 96 | PRKCE | 0.74889730 |
| 97 | PAK2 | 0.74875614 |
| 98 | CHUK | 0.74016222 |
| 99 | GSK3A | 0.69487965 |
| 100 | CSNK1A1L | 0.69251310 |
| 101 | PBK | 0.65072775 |
| 102 | MAP4K2 | 0.63926191 |
| 103 | MAP3K14 | 0.62551646 |
| 104 | SIK1 | 0.59942132 |
| 105 | ERBB3 | 0.59940343 |
| 106 | CAMK4 | 0.59773700 |
| 107 | MET | 0.58081581 |
| 108 | BMPR2 | 0.58009284 |
| 109 | GRK7 | 0.57599718 |
| 110 | CDK18 | 0.57041231 |
| 111 | CDK14 | 0.57028611 |
| 112 | CSNK1G1 | 0.56625765 |
| 113 | MAP3K5 | 0.56308903 |
| 114 | FES | 0.53654019 |
| 115 | PDGFRB | 0.53348974 |
| 116 | BCR | 0.53221089 |
| 117 | PAK1 | 0.52314245 |
| 118 | IKBKB | 0.51881441 |
| 119 | HIPK2 | 0.50885491 |
| 120 | RPS6KA3 | 0.50556450 |
| 121 | CDK15 | 0.50422219 |
| 122 | PINK1 | 0.50415518 |
| 123 | MARK2 | 0.50016955 |
| 124 | IRAK1 | 0.49399640 |
| 125 | DAPK3 | 0.49004408 |
| 126 | PTK2 | 0.48928873 |
| 127 | EPHB1 | 0.45376633 |
| 128 | RPS6KA2 | 0.43826679 |
| 129 | CDK3 | 0.43735293 |
| 130 | STK11 | 0.43444301 |
| 131 | TYRO3 | 0.42925249 |
| 132 | CDK11A | 0.42664422 |
| 133 | PRKCZ | 0.41340641 |
| 134 | FRK | 0.40901896 |
| 135 | MAPK7 | 0.40567415 |
| 136 | PDK1 | 0.40416511 |
| 137 | PRKG1 | 0.40378342 |
| 138 | PDPK1 | 0.39978697 |
| 139 | DDR2 | 0.37266937 |
| 140 | CAMK1D | 0.37071958 |
| 141 | ADRBK1 | 0.37038065 |
| 142 | CSNK1G2 | 0.35560377 |
| 143 | PNCK | 0.35367144 |
| 144 | PRKCA | 0.35361656 |
| 145 | OXSR1 | 0.34952939 |
| 146 | LMTK2 | 0.34925154 |
| 147 | STK10 | 0.34662349 |
| 148 | MAPK10 | 0.34480983 |
| 149 | CAMK2G | 0.34457107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.38834532 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.16831261 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78814338 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67994079 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.56136030 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 2.52487735 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.38598580 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.29618622 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.22706220 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.14682327 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.13806489 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.11901486 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.11470783 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09603819 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.99120078 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98301340 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93186018 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.91069422 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90849441 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.90091445 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.83113003 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79903402 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.72159526 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.71969443 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.66602234 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65982189 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63034268 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.62601606 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.60598024 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.60250006 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60037681 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.59574824 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56907070 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.56112021 |
| 35 | Amoebiasis_Homo sapiens_hsa05146 | 1.51584714 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.51454931 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47423406 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46212341 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.44317019 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41822007 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39993055 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39892438 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.38301354 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37975673 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 1.32709845 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31842762 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.29417161 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28691241 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28346553 |
| 50 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.28215508 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 1.22122260 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.20347954 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16220472 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15851738 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15609247 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 1.15191243 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14489649 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14129816 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13305678 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12146417 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11665098 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 1.09430706 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08015261 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06075672 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06037734 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05981552 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.04751321 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04023138 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03977360 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03582768 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00515627 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99871661 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98916671 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94973030 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94713054 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.91269609 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90181305 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89590077 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86830493 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.84735275 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.84249028 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83103849 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81530232 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.80093766 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79717672 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76100435 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75653822 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75109780 |
| 89 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.74510780 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73599710 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.71771888 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.71345274 |
| 93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70945611 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68718796 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.68223516 |
| 96 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.67080621 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66510030 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65802704 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64754976 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63598218 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62956165 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62636525 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.60161105 |
| 104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59641062 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57498429 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57169937 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56257061 |
| 108 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55191536 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54908538 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53831166 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53733159 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53624711 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53249531 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53081611 |
| 115 | Hepatitis B_Homo sapiens_hsa05161 | 0.52960471 |
| 116 | Tuberculosis_Homo sapiens_hsa05152 | 0.52796457 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.50222077 |
| 118 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49800129 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49714136 |
| 120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48760295 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48036902 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.47373528 |
| 123 | Protein export_Homo sapiens_hsa03060 | 0.47269456 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45897679 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45617245 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45588638 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44915880 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43838613 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42983432 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42973588 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41496483 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41196236 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40849812 |
| 134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40504916 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40044311 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.39579936 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.39526011 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37658214 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35662113 |
| 140 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35342265 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.33586791 |
| 142 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32491111 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31793869 |
| 144 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.31388682 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.31238769 |
| 146 | Bile secretion_Homo sapiens_hsa04976 | 0.30723849 |
| 147 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30030281 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.29343383 |
| 149 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26252097 |
| 150 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26156160 |
| 151 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25387905 |
| 152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24542974 |
| 153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24392260 |

